Durata Therapeutics, Inc. (DRTX) has 24 open-market insider trades by 21 insiders since 2012. The most active filer is Paul R. Edick, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Dov A. Goldstein M.D. | Dir10% | — | 1 | $10.0M | 2012-07-24 |
| Aisling Capital Partners III LLC | 10% | — | 1 | $10.0M | 2012-07-24 |
| Jesse I. Treu | 10% | — | 1 | $7.1M | 2012-07-24 |
| James C. Blair | 10% | — | 1 | $7.1M | 2012-07-24 |
| Philippe O. Chambon | 10% | — | 1 | $7.1M | 2014-11-17 |
| Ronald Hunt | Dir10% | — | 1 | $7.1M | 2012-07-24 |
| Brian K. Halak | 10% | — | 1 | $7.1M | 2012-07-24 |
| Kathleen K. Schoemaker | 10% | — | 1 | $7.1M | 2014-11-17 |
| Nicole Vitullo | Dir10% | — | 1 | $7.1M | 2012-07-24 |
| Brian H. Dovey | 10% | — | 1 | $7.1M | 2012-07-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| John Patrick Shannon Jr. | Chief Commercial Officer | Buy | $41K | 2014-08-12 |
| Paul R. Edick | CEO | Buy | $46K | 2014-06-12 |
| Richard U. de Schutter | Director | Buy | $234K | 2014-05-12 |
| Andrew N. Schiff | 10% | Sell | $1.6M | 2014-03-20 |
| Lisa M. Giles | Director | Buy | $11K | 2013-12-03 |
| Paul R. Edick | CEO | Buy | $21K | 2013-05-20 |
Companies that share insiders with DRTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul R. Edick | CEO | Buy | $43K | 2012-08-14 |
| Lisa M. Giles | Director | Buy | $4K | 2012-08-06 |
| Aisling Capital Partners III LLC | 10% | Buy | $10.0M | 2012-07-24 |
| Brenton Karl Ahrens | Director & 10% | Buy | $5.0M | 2012-07-24 |
| Brian H. Dovey | 10% | Buy | $7.1M | 2012-07-24 |
| DP VIII Associates, L.P. | 10% | Buy | $52K | 2012-07-24 |
| Domain Partners VIII, L.P. | 10% | Buy | $7.0M | 2012-07-24 |
| Venture Partners Vii L. P. Sofinnova | 10% | Buy | $5.3M | 2012-07-24 |